Clinical Trials

Phase I Clinical Trial: A Phase I, Multi-Center, Open-Label, Dose Escalation Study of Thrombosomes® in Bleeding Thrombocytopenic Patients in Three Cohorts
Status: Active, Not Recruiting
Learn More

Exploratory Phase I Trial: Safety Evaluation of Lyophilized Platelet-derived Hemostatic Product
Status: Completed 2016
Learn More


Have Questions?Reach us here

Please enter your information below

The Cellphire Method

Cellphire has developed a proprietary method for the long-term stabilization of blood cells in the dry state. The first application of this technology is to develop a freeze-dried hemostatic agent derived from platelets.